GLYCAM-1: Difference between revisions
Adeeljamil (talk | contribs) (New page: {{protein |Name=glycosylation dependent cell adhesion molecule-1 |caption= |image= |width= |HGNCid=18023 |Symbol=GLYCAM1 |AltSymbols= |EntrezGene=644076 |OMIM= |RefSeq=XM_927461 |U...) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 20: | Line 20: | ||
{{SI}} | {{SI}} | ||
'''Glycosylation-dependent [[cell adhesion molecule]]-1''' ('''GLYCAM1''') is a [[proteoglycan]] [[ligand]] expressed on cells of the [[high endothelial venule]]s in lymph nodes. It is able to bind to the receptor [[L-selectin]] during inflammation, acting as a homing beacon for [[leukocyte]]s expressing the receptor to enter the site of inflammation<ref name="robspath">{{cite book | title=Robbins Pathologic Basis of Disease| last=Cotran| coauthors=Kumar, Collins| publisher=W.B Saunders Company| location=Philadelphia| id=0-7216-7335-X}}</ref>. | '''Glycosylation-dependent [[cell adhesion molecule]]-1''' ('''GLYCAM1''') is a [[proteoglycan]] [[ligand]] expressed on cells of the [[high endothelial venule]]s in lymph nodes. It is able to bind to the receptor [[L-selectin]] during inflammation, acting as a homing beacon for [[leukocyte]]s expressing the receptor to enter the site of inflammation<ref name="robspath">{{cite book | title=Robbins Pathologic Basis of Disease| last=Cotran| coauthors=Kumar, Collins| publisher=W.B Saunders Company| location=Philadelphia| id=0-7216-7335-X}}</ref>. | ||
| Line 28: | Line 28: | ||
== References == | == References == | ||
{{reflist}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 17:37, 4 September 2012
| glycosylation dependent cell adhesion molecule-1 | |
|---|---|
| Identifiers | |
| Symbol | GLYCAM1 |
| Entrez | 644076 |
| HUGO | 18023 |
| RefSeq | XM_927461 |
| UniProt | Q8IVK1 |
| Other data | |
| Locus | Chr. 12 q13.2 |
|
WikiDoc Resources for GLYCAM-1 |
|
Articles |
|---|
|
Most recent articles on GLYCAM-1 |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on GLYCAM-1 at Clinical Trials.gov Clinical Trials on GLYCAM-1 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on GLYCAM-1
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating GLYCAM-1 Risk calculators and risk factors for GLYCAM-1
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for GLYCAM-1 |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Glycosylation-dependent cell adhesion molecule-1 (GLYCAM1) is a proteoglycan ligand expressed on cells of the high endothelial venules in lymph nodes. It is able to bind to the receptor L-selectin during inflammation, acting as a homing beacon for leukocytes expressing the receptor to enter the site of inflammation[1].
External links
- GlyCAM-1 at the US National Library of Medicine Medical Subject Headings (MeSH)